Three independent mechanisms for arrest in G2after ionizing radiation

Cell Cycle

Volumn 10, Issue 5, 2011, Pages 819-829

  Landsverk, Kirsti Solberg ^a   Patzke, Sebastian ^a   Rein, Idun Dale ^a   Stokke, Caroline ^a   Lyng, Heidi ^a   De Angelis, Paula M ^a   Stokke, Trond ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

ATM; Cell cycle checkpoints; CHEK1; Ionizing radiation; TP53

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; ATM PROTEIN; CAFFEINE; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; PROTEIN P53;

ARTICLE; B LYMPHOCYTE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; IRRADIATION; MITOSIS; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION;

EUKARYOTA;

EID: 79952336853     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.5.14968     Document Type: Article

References (62)

1. Hartwell LH, Weinert TA. Checkpoints: Controls that ensure the order of cell cycle events. Science 1989;246:629-34. (Pubitemid 19283354)
2. Murray AW. Creative blocks: Cell cycle checkpoints and feedback controls. Nature 1992; 359:599-604.
3. Elledge SJ. Cell cycle checkpoints: Preventing an identity crisis. Science 1996; 274:1664-72. (Pubitemid 26414889)
4. Pietenpol JA, Stewart ZA. Cell cycle checkpoint signaling: Cell cycle arrest versus apoptosis. Toxicology 2002;181:475-81. (Pubitemid 36015741)
5. Houtgraaf JH, Versmissen J, van der Giessen WJ. A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovasc Revasc Med 2006;7:165-72. (Pubitemid 44292065)
6. Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 2007; 19:238-45. (Pubitemid 46386406)
7. Clarke PR, Allan LA. Cell cycle control in the face of damage - a matter of life or death. Trends Cell Biol 2009; 19:89-98.
8. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 266:1821-8.
9. Orr-Weaver TL, Weinberg RA. A checkpoint on the road to cancer. Nature 1998; 392:223-4.
10. Kastan MB, Bartek J. Cell cycle checkpoints and cancer. Nature 2004; 432:316-23.
11. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-11.
12. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992;89:7491-5.
13. Nurse P. Universal control mechanism regulating onset of M-phase. Nature 1990; 344:503-8.
14. Nurse P, Thuriaux P. Regulatory genes controlling mitosis in the fission yeast Schizosaccharomyces pombe. Genetics 1980; 96:627-37. (Pubitemid 11103704)
15. Gould KL, Nurse P. Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis. Nature 1989; 342:39-45.
16. Mueller PR, Coleman TR, Kumagai A, Dunphy WG. Myt1: A membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science 1995; 270:86-90.
17. Strausfeld U, Labbe JC, Fesquet D, Cavadore JC, Picard A, Sadhu K, et al. Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein. Nature 1991; 351:242-5. (Pubitemid 21896574)
18. Sebastian B, Kakizuka A, Hunter T. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc Natl Acad Sci USA 1993; 90:3521-4. (Pubitemid 23111398)
19. 2 arrest after DNA damage. Science 1998;20:1497-501.
20. 2 DNA damage checkpoint. J Biol Chem 2000; 275:30638-43.
21. 2/M progression. Mol Cell 1997;1:3-11.
22. 2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene 2001; 20:7453-63.
23. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, et al. Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25. Science 1997; 277:1497-501. (Pubitemid 27449236)
24. Matsuoka S, Huang M, Elledge SJ. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998; 282:1893-7. (Pubitemid 28555269)
25. Chaturvedi P, Eng WK, Zhu Y, Mattern MR, Mishra R, Hurle MR, et al. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 1999; 18:4047-54. (Pubitemid 29363911)
26. Zhao H, Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 2001; 21:4129-39. (Pubitemid 32565295)
27. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998;281:1674-7.
28. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998; 281:1677-9. (Pubitemid 28435584)
29. Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci USA 1999; 96:13777-82.
30. Shieh SY, Ahn J, Tamai K, Taya Y, Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damageinducible sites. Genes Dev 2000; 14:289-300. (Pubitemid 30106484)
31. Hirao A, Cheung A, Duncan G, Girard PM, Elia AJ, Wakeham A, et al. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol Cell Biol 2002; 22:6521-32.
32. Smits VA, Klompmaker R, Arnaud L, Rijksen G, Nigg EA, Medema RH. Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol 2000; 2:672-6.
33. Kang D, Chen J, Wong J, Fang G. The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition. J Cell Biol 2002; 156:249-59. (Pubitemid 34839907)
34. 2 DNA-damage-response checkpoint. Cell 2008; 134:256-67.
35. Crawford DF, Piwnica-Worms H. The G(2) DNA damage checkpoint delays expression of genes encoding mitotic regulators. J Biol Chem 2001; 276:37166-77.
36. Lyng H, Landsverk KS, Kristiansen E, DeAngelis PM, Ree AH, Myklebost O, et al. Response of malignant B lymphocytes to ionizing radiation: Gene expression and genotype. Int J Cancer 2005; 115:935-42. (Pubitemid 40791835)
37. 2 DNA damage-induced arrest in mammalian cells. Mol Cell 2004; 15:799-811.
38. Schmidt M, Hofmann HP, Sanders K, Sczakiel G, Beckers TL, Gekeler V. Molecular alterations after Polo-like kinase 1 mRNA suppression versus pharmacologic inhibition in cancer cells. Mol Cancer Ther 2006; 5:809-17. (Pubitemid 43724579)
39. Xu B, Kim ST, Lim DS, Kastan MB. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell Biol 2002; 22:1049-59.
40. Brown EJ, Baltimore D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev 2003; 17:615-28. (Pubitemid 36307546)
41. 2 accumulation in irradiated AT cells. J Biol Chem 2003; 278:30869-74.
42. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, et al. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 2006; 8:37-45. (Pubitemid 43064795)
43. Cuadrado M, Martinez-Pastor B, Murga M, Toledo LI, Gutierrez-Martinez P, Lopez E, et al. ATM regulates ATR chromatin loading in response to DNA double-strand breaks. J Exp Med 2006; 20:297-303. (Pubitemid 43290838)
44. Blasina A, Price BD, Turenne GA, McGowan CH. Caffeine inhibits the checkpoint kinase ATM. Curr Biol 1999; 9:1135-8.
45. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 1999; 59:4375-82. (Pubitemid 29418757)
46. Zhou BB, Chaturvedi P, Spring K, Scott SP, Johanson RA, Mishra R, et al. Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J Biol Chem 2000; 275:10342-8.
47. Cortez D. Caffeine inhibits checkpoint responses without inhibiting the ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) protein kinases. J Biol Chem 2003; 278:37139-45. (Pubitemid 37175228)
48. Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, et al. Identification and characterization of a novel and specific inhibitor of the ataxiatelangiectasia mutated kinase ATM. Cancer Res 2004;64:9152-9. (Pubitemid 39665530)
49. 2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases. Cancer Res 2006;66:10253-7.
50. Landsverk KS, Lyng H, Stokke T. The response of malignant B lymphocytes to ionizing radiation: Cell cycle arrest, apoptosis and protection against the cytotoxic effects of the mitotic inhibitor nocodazole. Radiat Res 2004; 162:405-15. (Pubitemid 39388162)
51. Golsteyn RM, Schultz SJ, Bartek J, Ziemiecki A, Ried T, Nigg EA. Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. J Cell Sci 1994; 107:1509-17. (Pubitemid 24198470)
52. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71:587-97.
53. 2/M checkpoint. Nat Cell Biol 2009;11:1247-53.
54. 2/M checkpoint control. PLoS Genet 2010;6:1000863.
55. Rosenfeld C, Goutner A, Choquet C, Venuat AM, Kayibanda B, Pico JL, et al. Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line. Nature 1977; 267:841-3. (Pubitemid 8110160)
56. Nilsson K, Sundstrom C. Establishment and characteristics of two unique cell lines from patients with lymphosarcoma. Int J Cancer 1974; 13:808-23.
57. Tsuzuki S, Karnan S, Horibe K, Matsumoto K, Kato K, Inukai T, et al. Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: Analysis by means of array-based comparative genomic hybridization. Cancer Sci 2007; 98:698-706. (Pubitemid 46563446)
58. 2 phase nuclei with mithramycin, propidium iodide and ethidium bromide after fixation with formaldehyde. Cytometry 1986; 7:54-63.
59. De Angelis PM, Svendsrud DH, Kravik KL, Stokke T. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol Cancer 2006; 5:20.
60. Lyng H, Badiee A, Svendsrud DH, Hovig E, Myklebost O, Stokke T. Profound influence of microarray scanner characteristics on gene expression ratios: Analysis and procedure for correction. BMC Genomics 2004; 5:10.
61. 1 arrest in resulting tetraploid cells. Cancer Res 2001;61:7660-8.
62. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9:402-12.